Home › Prescription medicine › Contract Pharmaceuticals Limited Canada —…
Contract Pharmaceuticals Limited Canada — Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
The Recall Registry rates this labelling issue — FDA Class III: unlikely to cause harm.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: Contract Pharmaceuticals Limited Canada
The product
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61
Details
- Units affected
- 45,875 bottles
- Recall date
- February 20, 2024
- Brand
- Contract Pharmaceuticals Limited Canada
Nationwide in the U.S. and Puerto Rico
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Contract Pharmaceuticals Limited Canada — Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine